Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine TumorsSofia Koustoulidou, Maryana Handula, Corrina de Ridder, et al.The EMBO Journal|August 7, 2012
Generation of DNA single-strand displacement by compromised nucleotide excision repairCamille Godon, Sophie Mourgues, Julie Nonnekens, et al.Cancers|October 23, 2019
Apalutamide Sensitizes Prostate Cancer to Ionizing Radiation via Inhibition of Non-Homologous End-Joining DNA RepairWenhao Zhang, Chen-Yi Liao, Hajar Chtatou, et al.Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Mechanistic insights in transcription-coupled nucleotide excision repair of ribosomal DNALaurianne Daniel, Elena Cerutti, Lise-Marie Donnio, et al.Nuclear Medicine Communications|June 4, 2026
Radiobiological comparison of holmium-166 and yttrium-90 for hepatocellular carcinoma treatment in vitroJustine Perrin, Carolline Ntihabose, Tijmen H de Wolf, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Modeling Early Radiation DNA Damage Occurring During <sup>177</sup>Lu-DOTATATE Radionuclide TherapyGiulia Tamborino, Yann Perrot, Marijke De Saint-Hubert, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2015
Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical ModelsSimone U Dalm, Julie Nonnekens, Gabriela N Doeswijk, et al.EJNMMI Research|November 21, 2025
Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responsesPleun A M Engbers, Thom G A Reuvers, José María Heredia-Genestar, et al.Cancers|July 27, 2024
Investigating the Radiobiological Response to Peptide Receptor Radionuclide Therapy Using Patient-Derived Meningioma SpheroidsThom G A Reuvers, Vivian Grandia, Renata M C Brandt, et al.Theranostics|June 23, 2023
DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy <i>in vitro</i> and <i>in vivo</i>Thom G A Reuvers, Nicole S Verkaik, Debra Stuurman, et al.Pageof 6